Home
Conditions
Malaria, Falciparum

Clinical trial condition

Malaria, Falciparum

Explore clinical trials studying Malaria, Falciparum. Study availability and eligibility vary by location and protocol.

368 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Malaria, Falciparum trial results

Completed

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

NCT01594931

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Pailin General Hospital Pailin, Cambodia

Bethesday Hospital Tomohon, North Sulawesi, Indonesia

Centre de santé du roi Baudoin Guédiawaye, Senegal

Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand

View Trial Details

Completed

Pyronaridine - Artesunate (3:1) Versus Mefloquine Plus Artesunate in Plasmodium Falciparum Malaria Patients

NCT00403260

Conditions: Falciparum Malaria, Infections, Malaria, +5 more
Locations: RAOTAP2/Centre Muraz Bobo-Dioulasso, Houet Province, Burkina Faso

Pailin Referral Hospital Pailin, Cambodia

Institut Pasteur Abidjan, Côte d’Ivoire

Wentlock District Hospital Mangalore, India

View Trial Details

Completed

Safety, Tolerability and Protective Efficacy of PfSPZ Vaccine in Gabonese Children

NCT03521973

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Centre de Recherches Médicales de Lambaréné (CERMEL) Lambaréné, Moyen-Ogooué Province, Gabon

View Trial Details

Completed

Therapeutic Efficacy Study of AL and DP in Western Kenya

NCT05060198

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Not specified

View Trial Details

Completed

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

NCT02699099

Conditions: Infections, Malaria, Malaria Vaccines, +5 more
Locations: GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Kumasi, Ghana

View Trial Details

Completed

Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children

NCT03452475

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Kilifi County Hospital Kilifi, Kenya

View Trial Details

Completed

Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites

NCT04310085

Conditions: Infections, Inflammation, Malaria, +12 more
Locations: SGS Belgium NV Clinical Pharmacology Unit Antwerp, Belgium

View Trial Details

Completed

Safety, Immunogenicity, and Protective Efficacy of Two Regimens of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Natural Transmission Season in Healthy African Adults in Mali

NCT03510481

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Malaria Research and Training Center Bamako, Mali

View Trial Details

Completed

Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A

NCT01704508

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Bandim Health Project Bissau, Guinea-Bissau

View Trial Details

Completed

NMRC-M3V-Ad-PfCA Vaccine - Clinical Trial 1

NCT00392015

Conditions: Adenoviridae Infections, DNA Virus Infections, Infections, +8 more
Locations: Naval Medical Research Center (NMRC) Clinical Trials Center Bethesda, Maryland, United States

View Trial Details

Malaria, Falciparum

Malaria, Falciparum trial results

Related conditions